Top Story

Cleveland Clinic announces two appointments

October 13, 2015

Cleveland Clinic announced two faculty appointments.

Timothy Gilligan, MD, has been appointed vice chairman of education for Cleveland Clinic’s Taussig Cancer Institute. He will oversee and support the institute’s education activities, which include fellowship and residency programs; medical student and resident rotations; continuing education programs; and faculty development activities.

In the Journals

Poor dietary habits common among survivors of cancer

October 13, 2015
Cancer survivors demonstrated poor adherence to federal dietary guidelines and worse intake patterns for empty calories and fiber than the general population, according…
Jennifer Vaughn In the JournalsPerspective

Early post-chemotherapy discharge may be safe, cost-effective for patients with AML, MDS

October 12, 2015
The early discharge of patients with acute myeloid leukemia or myelodysplastic syndrome following intensive chemotherapy can reduce costs and the use of IV antibiotics…
Chyke Doubeni, MD In the Journals

Older individuals with one relative with CRC may not need aggressive screening

October 12, 2015
A recent study found only a small increase in risk for colorectal cancer incidence and death among older individuals who have only one first-degree relative diagnosed…
Drug Pipeline

EMA grants orphan drug designation to CF102 for HCC

October 12, 2015
The European Medicines Agency has granted orphan drug designation to Can-Fite BioPharma Ltd.’s CF102, a potential drug to treat hepatocellular carcinoma, according…
More News Headlines »
Hematology Oncology Case Consults

The Patient with Pancreatic Cancer

No commercial support for this activity.

Pancreatic cancer only accounts for 3% of cancer cases, but it is the fourth leading cause of cancer-related death…
More »
VIDEO: Targeted combination therapies become touchstone for care in advanced melanoma

VIDEO: Targeted combination therapies become touchstone for care in advanced melanoma

September 30, 2015
The development of new treatments for patients with advanced melanoma in the past decade has been…
More »
Diabetic Eye Disease Consults: Volume 1, Number 1

Updates in Melanoma 2015: Entering a New Therapeutic Era

This activity is supported by an educational grant from Merck & Co., Inc.

The incidence of melanoma, an aggressive disease that accounts for approximately 75% of skin-cancer-related deaths, is…
More »